Xalkori Adverse Event Report 2018


This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions


Xalkori (crizotinib) is a cancer medication that interferes with the growth and spread of cancer cells in the body. Xalkori is used to treat non-small cell lung cancer that has spread to other parts of the body. Xalkori may also be used for purposes not listed in this medication guide.https://www.drugs.com/xalkori.html